Skip to content

Hims & Hers plummets 13% after first-quarter loss, weak earnings guidance · Stateside Daily

Stateside DailyAll America

Search Get alerts

Home›Business›1 sources

Business · 1 sources covering this

Hims & Hers plummets 13% after first-quarter loss, weak earnings guidance

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·3h ago
Hims & Hers plummets 13% after first-quarter loss, weak earnings guidance
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
Read at CNBC →

More from Business

CNBCLean R·29m ago

OpenAI trial updates: Musk lawyer presses Altman about their relationship in tense moment

CNBCLean R·33m ago

Amex adds first-of-its-kind AI benefit: $300 ChatGPT credit for Business Platinum and Business Gold Cards

Daily briefing

Stateside Daily in your inbox

The 5 stories from all america you actually need to read. Once a day, no fluff. Unsubscribe in one click.

Stateside Daily

About
Methodology
Sources
Careers
Contact
Editorial standards

Sections

Politics
Business
Markets

New York TimesLean L·34m ago

Conan O’Brien Will Return as Oscars Host

CNBCLean R·47m ago

Laid-off GM employees tell of ominous email, severance and role of AI

Reader

Notifications
Bookmarks
Search
Personal feed

Trust & legal

Corrections
Privacy
Terms
Security

Across the network

Hindustan Sphere
All India in one feed

© 2026 Stateside Daily. All headlines are sourced from third-party publishers; we never republish article bodies.

All America